L-type and T-type voltage-dependent calcium channels (LTCC and TTCC)

L-type and T-type voltage-dependent calcium channels (VDCCs) are critical membrane proteins that regulate the entry of calcium ions into cells in response to membrane depolarization (UniProt, 2024). L-type channels (Cav1 family) are high-voltage activated and are primarily responsible for excitation-contraction coupling in skeletal, cardiac, and smooth muscle, as well as hormone secretion in endocrine cells (StatPearls, 2024). T-type channels (Cav3 family) are low-voltage activated and play a key role in regulating cellular excitability, pacemaking activity in the heart, and rhythmic firing in the central nervous system (PubMed, 2014). Dysregulation of these channels is implicated in various pathologies, including hypertension, cardiac arrhythmias, epilepsy, and chronic pain (NIH, 2023). Pharmacological modulation of these channels, particularly through calcium channel blockers (CCBs), is a cornerstone of cardiovascular therapy (CV Pharmacology, 2024). While many traditional CCBs are selective for L-type channels, dual L/T-type blockers offer additional benefits such as improved renal protection and reduced reflex tachycardia (Hypertension, 2009). These drugs work by binding to specific subunits of the channel complex to stabilize the inactivated state, thereby reducing calcium-mediated signaling and physiological responses (Wikipedia, 2024).

Other names

Cav1 and Cav3 channelsHigh-voltage activated (HVA) and Low-voltage activated (LVA) calcium channelsVoltage-gated calcium channels (VGCCs)Dihydropyridine-sensitive and transient calcium channels

Inhibition of calcium ion influx through the channel pore by binding to the alpha-1 subunit, stabilizing the inactivated state, leading to vasodilation, reduced cardiac contractility, or decreased neuronal excitability.